Veritas Pharma Inc. announced earnings results for the second quarter ended October 31, 2020. For the second quarter, the company announced net loss was CAD 264,679 compared to CAD 255,439 a year ago. Basic loss per share was CAD 0.02 compared to CAD 0.02 a year ago. For the half year, net loss was CAD 408,976 compared to CAD 1.153 million a year ago. Basic loss per share was CAD 0.03 compared to CAD 0.09 a year ago.